GIG Works Inc. Logo

GIG Works Inc.

Connects businesses with gig workers, offering staffing, BPO, IT, and coworking services in Japan.

2375 | T

Overview

Corporate Details

ISIN(s):
JP3410750008
LEI:
Country:
Japan
Address:
港区西新橋二丁目11番6号 ニュー西新橋ビル3階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

GIG Works Inc. is a holding company operating a platform within the gig economy, connecting businesses with a flexible workforce of individual contractors. The company's core mission is to address labor market challenges by serving as a central hub for flexible work arrangements. Its business is organized into four key service areas: a GiGWork platform for on-demand staffing; comprehensive On-demand BPO services including fieldwork, call centers, and sales promotions; Professional IT services covering system development and technical support; and Sharing services that provide coworking spaces and entrepreneurial support. Through these integrated offerings, GIG Works aims to facilitate new ways of working and support business growth in Japan.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-11 09:07
Interim Report
確認書
Japanese 8.9 KB
2025-06-11 09:06
Interim Report
半期報告書-第49期(2024/11/01-2025/04/30)
Japanese 271.8 KB
2025-01-31 06:18
Post-Annual General Meeting Information
臨時報告書
Japanese 23.7 KB
2025-01-30 07:11
Governance Information
内部統制報告書-第48期(2023/11/01-2024/10/31)
Japanese 24.6 KB
2025-01-30 07:10
Registration Form
確認書
Japanese 9.3 KB
2025-01-30 07:09
Annual Report
有価証券報告書-第48期(2023/11/01-2024/10/31)
Japanese 1.3 MB
2024-06-11 08:18
Report Publication Announcement
確認書
Japanese 9.0 KB
2024-06-11 08:17
Quarterly Report
四半期報告書-第48期第2四半期(2024/02/01-2024/04/30)
Japanese 258.6 KB
2024-03-12 07:15
Quarterly Report
四半期報告書-第48期第1四半期(2023/11/01-2024/01/31)
Japanese 219.4 KB
2024-03-12 07:15
Report Publication Announcement
確認書
Japanese 9.4 KB
2024-02-02 07:07
Post-Annual General Meeting Information
臨時報告書
Japanese 29.3 KB
2024-01-30 08:00
Governance Information
内部統制報告書-第47期(2022/11/01-2023/10/31)
Japanese 24.0 KB
2024-01-30 08:00
Registration Form
確認書
Japanese 9.0 KB
2024-01-30 07:58
Registration Form
有価証券報告書-第47期(2022/11/01-2023/10/31)
Japanese 1.3 MB
2023-09-11 09:15
Report Publication Announcement
確認書
Japanese 9.0 KB

Automate Your Workflow. Get a real-time feed of all GIG Works Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GIG Works Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GIG Works Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.